liver cancer May 9, 2022 SCG Cell Therapy to Begin Trials of T-Cell Receptor Therapy for Liver Cancer Patients in Singapore Apr 29, 2022 Merck Nabs European Approvals for Keytruda in Cervical Cancer, Biomarker-Defined Solid Tumors Feb 8, 2022 Biocartis, Ophiomics Partner to Commercialize Gene Expression Prognostic Test for Liver Cancer Jan 4, 2022 GC Cell Licenses Liver Cancer Cell Therapy to Rivaara Immune in India Sep 23, 2021 Lion TCR to Begin Phase Ib/II Trial of Autologous Liver Cancer T-Cell Receptor Therapy Jul 29, 2021 Genetron Health Partners with Guizhou Local Government for Liver Cancer Early Screening Project Jul 20, 2021 Micronoma, University of New South Wales to Develop Liver Cancer Dx Using $4M Grant Jul 12, 2021 Perspectum Launches Study of Digital Pathology, WGS to Guide Liver Cancer Treatment Jun 24, 2021 Overexpressed Cancer Testis Antigen Could Reflect Therapeutic Target in Liver Cancer Jun 21, 2021 Berry Oncology, Alibaba Health Partner to Offer Early Cancer Screening, Health Services Jun 4, 2021 Surface Oncology, Roche Studying IL-27 Antibody With Tecentriq, Avastin in Liver Cancer Mar 25, 2021 Genetron Health Updates Data from Prospective Liquid Biopsy Liver Cancer Screening Study Premium Feb 17, 2021 Exact Sciences Sketches Out Strategy for End-to-End Cancer Testing With Ashion Acquisition Premium Oct 9, 2020 Eureka Therapeutics Begins Trial Assessing T-cell Therapy in Certain Liver Cancer Patients Sep 16, 2020 Startup Stitch Bio Bets on CRISPR Tech to Render Cancer Cells With Gene Fusions Druggable Premium Apr 29, 2020 Exploratory Study Finds Genomic Markers of Response to Tecentriq, Avastin in Advanced Liver Cancer Aug 29, 2019 Metabolic Assay Shows Promise in Predicting Treatment Response in Lung Cancer Study Premium May 1, 2019 Exact Sciences Ramps Up Plans for Pipeline Development as Cologuard Market Share Grows Premium Jun 20, 2018 Merck KGaA Advancing Tepotinib in MET-Altered Cancer Subpopulations Premium Jun 15, 2018 PDL1 Amplifications Mark Subset of Solid Tumors, May Point to Checkpoint Blockade Response Breaking News In Brief This Week: Gilead Sciences, Arcus Biosciences, Verismo Therapeutics, Caris Life Sciences Pyxis Oncology Gets FDA Permission to Start Phase I Trials of Anti-EDB Drug, Immunotherapy FDA Approves Rigel Pharmaceuticals' Rezlidhia for IDH1-Mutant AML Sofie Biosciences to Begin Trial of Fluorine-Labeled PET Diagnostic Imaging Agent for GI Cancers Study Unearths Features Found in Long-Term Survivors of Advanced Ovarian Cancer Carrick Therapeutics Receives $35M Investment From Pfizer; Raises $25M in Series C Funding Round
